Cala Health, Inc. - Cala Health raises $50 Million in Series C funding investment that will fund the commercial introduction of Cala Trio and expansion of the therapeutic platform. Learn more at
Cala Health® on Twitter: "Exciting news from Cala Health: The #FDA has granted Breakthrough Device Designation to #CalaTrio for the treatment of action tremors in the hands of adults with #ParkinsonsDisease. Read
How a watch helped Emma write again
Covid-19. Ils conçoivent un bracelet distributeur de gel hydroalcoolique - Saint-Nazaire.maville.com